INSL3 ligand-receptor system in the equine testis

被引:27
作者
Klonisch, T
Steger, K
Kehlen, A
Allen, WR
Froehlich, C
Kauffold, J
Bergmann, M
Hombach-Klonisch, S
机构
[1] Univ Halle Wittenberg, Dept Anat & Cell Biol, Fac Med, D-06097 Halle Saale, Germany
[2] Univ Halle Wittenberg, Dept Immunol, Fac Med, D-06097 Halle Saale, Germany
[3] Univ Giessen, Inst Vet Anat, D-35392 Giessen, Germany
[4] Univ Cambridge, Dept Clin Vet Med, Equine Fertil Unit, Newmarket CB8 9BH, Suffolk, England
[5] Univ Leipzig, Large Anim Clin Theriogenol & Ambulatory Serv, Fac Vet Med, D-04103 Leipzig, Germany
关键词
Leydig cells; placenta; relaxin; trophoblast;
D O I
10.1095/biolreprod.102.008466
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We employed molecular and immunological techniques to investigate the expression of INSL3, a member of the insulin-like superfamily, in prepubertal testis, postpubertal testes exhibiting normal and disturbed spermatogenesis, and cryptorchid testes of male horses. In addition, the partial cDNA coding sequences of the equine homologue of the human relaxin/INSL3receptor Lgr8 were determined. Nonradioactive in-situ hybridization with a cRNA probe for equine lnsl3 and immunohistochemistry with a specific rabbit INSL3 antiserum localized lnsl3 transcripts and immunoreactive INSL3 ligand to Leydig cells in all types of testes investigated. Quantitative polymerase chain reaction analysis revealed a down-regulation of InsI3 and an upregulation of the relaxin/INSL3-receptor expression in unilateral cryptorchid versus descended testes. Western blot analysis of protein extracts from adult normal and cryptorchid testes and prepubertal testes showed a single immunoreactive band at 14.5 kDa, which correlates with the predicted size of equine pro-INSL3. Densitometric analysis of Western blot data of adult normal testes revealed significantly stronger expression of immunoreactive proINSL3 as compared to extracts derived from cryptorchid or prepubertal testes. Thus, decreased expression of immunoreactive INSL3 in cryptorchid and prepubertal equine testis is transcriptionally regulated. The detection of transcripts for equine Lgr8 in the testis has identified the testis as a potential target of INSL3.
引用
收藏
页码:1975 / 1981
页数:7
相关论文
共 50 条
[1]   The role of the testicular factor INSL3 in establishing the gonadal position [J].
Adham, IM ;
Emmen, JMA ;
Engel, W .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2000, 160 (1-2) :11-16
[2]  
ADHAM IM, 1993, J BIOL CHEM, V268, P26668
[3]   Relaxin-like factor expression as a marker of differentiation in the mouse testis and ovary [J].
Balvers, M ;
Spiess, AN ;
Domagalski, R ;
Hunt, N ;
Kilic, E ;
Mukhopadhyay, AK ;
Hanks, E ;
Charlton, HM ;
Ivell, R .
ENDOCRINOLOGY, 1998, 139 (06) :2960-2970
[4]   Relaxin-like factor gene is highly expressed in the bovine ovary of the cycle and pregnancy: Sequence and messenger ribonucleic acid analysis [J].
Bathgate, R ;
Balvers, M ;
Hunt, N ;
Ivell, R .
BIOLOGY OF REPRODUCTION, 1996, 55 (06) :1452-1457
[5]  
BERNDTSON WE, 1989, J REPROD FERTIL, V85, P511, DOI 10.1530/jrf.0.0850511
[6]   Testicular concentration of meiosis-activating sterol is associated with normal testicular descent [J].
Bogh, IB ;
Baltsen, M ;
Byskov, AG ;
Greve, T .
THERIOGENOLOGY, 2001, 55 (04) :983-992
[7]   Relaxin-like factor (RLF) serum concentrations and gubernaculum RLF receptor display in relation to pre- and neonatal development of rats [J].
Boockfor, FR ;
Fullbright, G ;
Büllesbach, EE ;
Schwabe, C .
REPRODUCTION, 2001, 122 (06) :899-906
[8]   The relaxin-like factor is a hormone [J].
Büllesbach, EE ;
Rhodes, R ;
Rembiesa, B ;
Schwabe, C .
ENDOCRINE, 1999, 10 (02) :167-169
[9]   A HUMAN CDNA CODING FOR THE LEYDIG INSULIN-SILE PEPTIDE (LEY I-L) [J].
BURKHARDT, E ;
ADHAM, IM ;
HOBOHM, U ;
MURPHY, D ;
SANDER, C ;
ENGEL, W .
HUMAN GENETICS, 1994, 94 (01) :91-94
[10]   Involvement of insulin-like factor 3 (Insl3) in diethylstilbestrol-induced cryptorchidism [J].
Emmen, JMA ;
Mcluskey, A ;
Adham, IM ;
Engel, W ;
Verhoef-Post, M ;
Themmen, APN ;
Grootegoed, JA ;
Brinkmann, AO .
ENDOCRINOLOGY, 2000, 141 (02) :846-849